Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Seroprevalence of HBsAg, Anti-HBs, anti-HDV and HDVAg in İnönü University Medical Faculty Hospital, 2012 [İnönü Üniversitesi Tıp Fakültesi Hastanesinde, 2012 Yılında, HBsAg, Anti-HBs, Anti-HDV ve HDVAg Seroprevalansı]

Yücel Duman, Mehmet Sait Tekerekoğlu, Selma Ay.




Abstract

This study aimed to determine the seroprevalence of HBV and HDV in our hospital by examining the test results of HBsAg, anti-HBs, anti-HDV and HDV-Ag. Test results were evaluated retrospectively from the sera which obtained from patients admitted to hospital with suspected hepatitis in Inonu University Faculty of Medicine, 2012. The presence of HBsAg and anti-HBs in sera was investigated by using the macro ELISA Abbot - Architect i2000 system test kits, the presence of anti-HDV and HDV-Ag was investigated by micro-ELISA (Alisei, Seac Radim Comp. Rome, Italy) method. 14 522 sera were studied. 2093 (14%) of them were positive for HBsAg and 6758 (47%) were positive for anti-HBs. Among HBsAg positive sera; 316 (15%) were positive for anti-HDV and 6 (0.3%) were positive for HDV-Ag. During HBV and HDV infections considering the complications, financial aspects of cases treatment; vaccination against HBV, preventive measures and education should be given priority issues.

Key words: Hepatitis Delta Virus, Hepatitis B Virus, anti-HDV, HBsAg, Seroprevalence






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.